DiviDrip · HALO

HALO — Halozyme Therapeutics, Inc.

HALO is Halozyme Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $110.19. Market cap: $12.51B. Capital Quality Rank: 95/100 — Market alpha.

Stock snapshot

Price$110.19
Market cap$12.51B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)95 / 100 · Market alpha
ROIC (TTM)19.9%
Revenue CAGR (3y)28.4%
Shareholder buyback yield4.46%
Altman Z-score zoneSafe

About HALO

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Listed2004Employees423HQSan Diego, CASectorHealthcareWebsitehalozyme.com

Related non-dividend companies

Other non-dividend stocks investors research alongside HALO. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is HALO's current stock price?

HALO (Halozyme Therapeutics, Inc.) is currently trading at $110.19.

Does HALO pay a dividend?

HALO (Halozyme Therapeutics, Inc.) does not currently pay a regular dividend.

What is HALO's Capital Quality Rank?

HALO has a Capital Quality Rank of 95/100 — Market alpha. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track HALO in DiviDrip

Add HALO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow